Prednisone for community-acquired pneumonia: Not yet time

The Lancet

Volumn 386, Issue 9992, 2015, Pages 431-

  Baskar, Varadarajan ^a   Sum, Chee Fang ^a   Lim, Su Chi ^a  

^a KHOO TECK PUAT HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; PREDNISONE; ANTIINFLAMMATORY AGENT;

COMMUNITY ACQUIRED PNEUMONIA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LETTER; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; FEMALE; MALE; PNEUMONIA;

ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; MALE; PNEUMONIA; PREDNISONE;

EID: 84938583829     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)61445-3     Document Type: Letter

References (6)

1. CA Claudine Blum, N Nigro, M Briel et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial Lancet 385 2015 1511 1518
2. D Annane Corticosteroids and pneumonia: time to change practice Lancet 385 2015 1484 1485
3. I Ferreira-Gonzalez, G Permanyer-Miralda, JW Busse et al. Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns J Clin Epidemiol 60 2007 651 657
4. LG Hemkens, U Grouven, R Bender, PT Sawicki Insufficient evaluation of adverse events is not a proof of safety Diabetologia 53 2010 790 792
5. Y Hirata, H Tomioka, R Sekiya et al. Association of hyperglycemia on admission and during hospitalization with mortality in diabetic patients admitted for pneumonia Intern Med 52 2013 2431 2438
6. W Nie, Y Zhang, J Cheng, Q Xiu Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis PLoS One 7 2012 e47926